News & Updates
Filter by Specialty:
![Lenalidomide plus R-CHOP effective for untreated DLBCL patients](https://sitmspst.blob.core.windows.net/images/articles/covid-19-mortality-risk-in-thoracic-cancer-age-chemotherapy-contributing-factors-ec245f63-c6c8-418d-8a74-7768dd4bf806-square.jpg)
Lenalidomide plus R-CHOP effective for untreated DLBCL patients
16 Oct 2021
Combining lenalidomide with R-CHOP* (R2CHOP) yields durable and high rates of treatment response in untreated patient with diffuse large B-cell lymphoma (DLBCL), a recent study has found.
Lenalidomide plus R-CHOP effective for untreated DLBCL patients
16 Oct 2021![Diabetes, hypertension up risk of stroke](https://sitmspst.blob.core.windows.net/images/articles/silent-mi-may-increase-stroke-risk-in-older-adults-0b205601-da18-4cbc-8a13-b4946ad0c582-square.jpg)
Diabetes, hypertension up risk of stroke
16 Oct 2021
Hypertension and diabetes are the major predictors of stroke that must be controlled and treated like other global high-risk populations for stroke prevention, according to a prospective study in India.
Diabetes, hypertension up risk of stroke
16 Oct 2021![Marine n-3 PUFAs do not affect incident PAD risk](https://sitmspst.blob.core.windows.net/images/articles/oily-fish-bea81b13-b267-4ac5-a674-9ac6d4935535-square.jpg)
Marine n-3 PUFAs do not affect incident PAD risk
16 Oct 2021
Higher intake of marine n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exerts no significant protective effect against incident peripheral artery disease (PAD), a recent study has found.